Latest News & Features
Americas
Italy-based research organisation IRBM has signed a new agreement with Merck & Co in the peptides therapeutics area, extending the parties’ long-standing collaboration. 5 September 2018
Big Pharma
The European Medicines Agency has reportedly put a stop to the UK’s role in evaluating new EU medicines for sale as Brexit looms. 4 September 2018
Americas
As the tide of M&A activity continues to rise across the life sciences industry, LSIPR speaks to Tracy MacNeal of Ximedica on what’s driving the trend and the pitfalls to be aware of. 4 September 2018
Americas
Stephen Knight was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 4 September 2018
Asia
The Bombay High Court has imposed Rs 1.5 crore of costs on a pharmaceutical company which infringed India-based Glenmark Pharmaceuticals’ trademarks. 3 September 2018
Americas
Kush Parmar was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 3 September 2018
Americas
Mark Remus of Brinks Gilson & Lione discusses two patent-related challenges for generic pharmaceutical companies and how they might be overcome. 3 September 2018
Americas
A former GSK researcher has pleaded guilty to conspiring to steal trade secrets, in what prosecutors said was a scheme to benefit a Chinese pharmaceutical company. 3 September 2018
Americas
A proposal in the North American Free Trade Agreement to set the length of biologic data exclusivity at ten years would harm patients, according to generic associations. 31 August 2018
Americas
A report released this week by non-profit MassBio has shown that Massachusetts companies “dominated” the landscape for US initial public offerings (IPOs) of biotech companies in 2017. 31 August 2018